Issue 26
Get instant access to latest e-book

latest newsRead more...

23

Mar 2017

Aprea Therapeutics Announces Research Collaboration with Memorial Sloan Kettering Cancer Center

Aprea Therapeutics a privately held clinical stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor protein p today announced a collaboration with Memorial Sloan Kettering Cancer Center to study the effects of reactivation of tumor suppressor protein p by APR The goal of…

23

Mar 2017

Moleculin Receives Orphan Drug Designation for Annamycin

Moleculin Biotech Inc a preclinical pharmaceutical company focused on the development of anticancer drug candidates some of which are based on license agreements with The University of Texas System on behalf of the MD Anderson Cancer Center today announced its lead candidate Annamycin also known…

23

Mar 2017

Intec Pharma Initiates Phase I Trial of Accordion Pill for Cannabinoid Therapies

Intec Pharma Ltd a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology announces the initiation of a Phase I clinical trial of APCBDTHC its Accordion Pill platform with the two primary cannabinoids contained in Cannabis sativa cannabidiol…

press releasesRead more...

23

Mar 2017

Piramal Pharma Solutions Augments Integrated Capabilities by Expanding Sterile Manufacturing Capabilities in Lexington, KY

Piramal Pharma Solutions PPS a leading Contract Development and Manufacturing Organization CDMO held a special event to introduce the new and expanded manufacturing capabilities at its facilities in Lexington Kentucky…

23

Mar 2017

Shire Receives FDA Fast Track Designation for Recombinant ADAMTS13 (SHP655) for Treatment of Hereditary Thrombotic Thrombocytopenic Purpura

Shire plc today announced that the United States Food and Drug Administration FDA has granted Fast Track designation for recombinant ADAMTS SHP historically known as BAX for treatment of acute…

22

Mar 2017

X-Chem and Ono Enter into Multi-Target Drug Discovery Collaboration

XChem Inc a privately held biotechnology company applying its innovative drug discovery platform to the generation of novel small molecule therapeutics today announced a partnership with Ono Pharmaceutical Co Ltd…

EventsRead more...

22-24

Mar 2017

CPhI South East Asia

UBM
Jakarta International Expo

22-24

Mar 2017

TOP ARTICLES

  • 2

    Parenteral Preparations

    INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or infusion powders for injection or infusion gels for injecti..

Knowledge Bank

  • Interviews

    Datwyler Pharma Packaging

    Senior Manager Global Scientific Affairs
    Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Re..

  • Articles

    Improving Biopharma Productivity through Optimal Bioreactor Operation

    Generating global revenue of US billion biopharmaceuticals account for one fifth of pharmaceutical market The revenue grows at per cent annually which is double that of conventional pharmaceutical products The growing demand for therapeutic proteins and increasing focus from regulatory bodies have confronted the industry with challenges of ensuring affordability delivery and consistent quality…

  • Techno Trends

    New Liquid Biopsy Chip Allows to Trap Cancer Cells Easily

    Worcester Polytechnic Institute WPI researchers have developed a new chip that traps and identifies metastatic cancer cells within a tiny amount of blood drawn from a cancer patient Liquid Biopsy technique helps to capture and identify tumour cells andor DNA This technology uses a simple mechanical method which is efficient in trapping cancer cells than the micro fluidic approach used…

Editorial Section

  • Strategy

    Generics in Switzerland

    The article talks about the Swiss Generics market the penetration rate of generics in Switzerland why generics are a safe and smarter choice manufactured to modern standards with affordable prices and the threat of government forcing generic companies to benchmark…

  • Research development

    Biologics and Biosimilars

    With the early generation of biologics starting to lose patent protection the field of biosimilars too has been gaining attention Biosimilars are the generic version of a biologic drug developed for launch post the patent expiry of the original drug…

  • Clinical Trails

    Patient Recruitment

    To address the challenges faced in patient recruitment and retention in clinical trials innovative technologies are being utilised in AsiaPacific as well as other regions to optimise the processes involved From patient matching to improving the consent process technology has…

  • Expert Talk

    Biologics’ Drug Delivery Systems

    In this interview Peter Soelkner of Vetter discusses drug delivery trends for biologics and in particular prefilled syringes He offers insight into the advantages and challenges of this system for biologics important issues to consider…

TOP